ZOM
Price:
$0.1277
Market Cap:
$125.14M
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment of various musculoskeletal issues, such as broken bones, tendonitis, and torn ligaments in horses and small animals. It has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for development ...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2017-11-21
Stock Exchange
AMEX
Ticker
ZOM
According to Zomedica Corp.’s latest financial reports and current stock price. The company's current PE Ratio is -2.13. This represents a change of -31.60% compared to the average of -3.11 of the last 4 quarters.
The mean historical PE Ratio of Zomedica Corp. over the last ten years is -11.61. The current -2.13 PE Ratio has changed 1.73% with respect to the historical average. Over the past ten years (40 quarters), ZOM's PE Ratio was at its highest in in the March 2019 quarter at -0.66. The PE Ratio was at its lowest in in the February 2016 quarter at -1030.81.
Average
-11.61
Median
-11.57
Minimum
-21.43
Maximum
-1.78
Discovering the peaks and valleys of Zomedica Corp. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 442.25%
Maximum Annual PE Ratio = -1.78
Minimum Annual Increase = -74.02%
Minimum Annual PE Ratio = -21.43
Year | PE Ratio | Change |
---|---|---|
2023 | -5.68 | -39.47% |
2022 | -9.39 | -41.14% |
2021 | -15.95 | 221.11% |
2020 | -4.97 | 179.81% |
2019 | -1.78 | -74.02% |
2018 | -6.83 | -68.11% |
2017 | -21.43 | 55.84% |
2016 | -13.75 | -18.19% |
2015 | -16.81 | -14.04% |
2015 | -19.55 | 442.25% |
The current PE Ratio of Zomedica Corp. (ZOM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-10.34
5-year avg
-7.55
10-year avg
-11.61
Zomedica Corp.’s PE Ratio is greater than Tilray Brands, Inc. (-5.52), less than Aurora Cannabis Inc. (-0.47), less than Canopy Growth Corporation (-0.82), less than HEXO Corp. (-0.02), greater than OrganiGram Holdings Inc. (-3.03), less than Shuttle Pharmaceuticals Holdings, Inc. (-0.21), less than Mallinckrodt plc (-0.04), less than Agile Therapeutics, Inc. (-0.65), less than Lifecore Biomedical, Inc. (36.01), greater than Aquestive Therapeutics, Inc. (-12.45), less than Lucy Scientific Discovery Inc. (-1.23), greater than Alimera Sciences, Inc. (-20.50), less than Adamis Pharmaceuticals Corporation (-0.67), less than Athenex, Inc. (-0.01), greater than Cronos Group Inc. (-16.75), greater than SNDL Inc. (-6.54),
Company | PE Ratio | Market cap |
---|---|---|
-5.52 | $1.21B | |
-0.47 | $254.08M | |
-0.82 | $485.78M | |
-0.02 | $31.24M | |
-3.03 | $165.03M | |
-0.21 | $2.98M | |
-0.04 | $4.52M | |
-0.65 | $10.43M | |
36.01 | $280.99M | |
-12.45 | $438.57M | |
-1.23 | $906.91K | |
-20.50 | $301.29M | |
-0.67 | $7.25M | |
-0.01 | $2.33M | |
-16.75 | $791.35M | |
-6.54 | $515.07M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Zomedica Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Zomedica Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Zomedica Corp.'s PE Ratio?
How is the PE Ratio calculated for Zomedica Corp. (ZOM)?
What is the highest PE Ratio for Zomedica Corp. (ZOM)?
What is the 3-year average PE Ratio for Zomedica Corp. (ZOM)?
What is the 5-year average PE Ratio for Zomedica Corp. (ZOM)?
How does the current PE Ratio for Zomedica Corp. (ZOM) compare to its historical average?